Most Read Articles
Jairia Dela Cruz, 05 Dec 2017
Discontinuation of aspirin may have detrimental consequences for long-term users, with a recent study reporting that cessation of use in the absence of major surgery or bleeding increases the risk of cardiovascular events.
19 Dec 2016
The prevalence of ECG for left ventricular hypertrophy (LVH) may vary depending on the criteria used across body mass index (BMI) categories in a low cardiovascular risk cohort, suggests a new study.
01 Mar 2015
Red yeast rice extracts have been used in traditional medicine for centuries.1 In recent times, an extract from red yeast rice, Xuezhikang® (XZK), has been studied for its role in dyslipidaemia and cardiovascular disease. This review will look at some of the clinical trials that have done so.
Pearl Toh, 8 hours ago
A higher dose of pitavastatin can benefit Japanese patients with stable coronary artery disease (CAD) compared with a low-dose pitavastatin, even though cardiovascular (CV) event incidence is known to be lower in Asian than Western patients, according to the REAL-CAD study presented at the AHA Scientific Sessions 2017.

Factors predicting increased 1-year mortality among heart transplant recipients

27 Sep 2017

Recipient and donor age, congenital aetiology, creatinine, pulsatile mechanical circulatory support (MCS), and donor-recipient gender mismatch all contribute to an increase in 1-year mortality among heart transplant recipients, according to a study.

Researchers performed a systematic review and meta-analysis of 62 studies including 282,367 heart recipients transplanted between 1983 and 2013. Males comprised the majority of both recipients (67 to 91) and donors (49 to 72 percent), and the mean age ranged from 32 to 55 years among donors and 29 to 44 years among recipients.

About half of the included studies specified 1 year as the time point of interest for outcome, with 93.6 percent reporting on all-cause mortality. The median risk of 1-year mortality was 15 percent.

In random-effects models, pooled risk estimates showed 1-year mortality to be significantly associated with recipient variables including age (hazard ratio [HR], 1.16 per 10-year increase; 95 percent CI, 1.10 to 1.22), congenital aetiology (HR, 2.35; 1.62 to 3.41), diabetes (HR, 1.37; 1.15 to 1.62), creatinine (HR, 1.11 per 1-mg/dL increase; 1.06 to 1.16), mechanical ventilation (HR, 2.46; 1.48 to 4.09) and short-term MCS (HR, 2.47; 1.04 to 5.87). Quality of evidence was moderate to high.

Among donor-related factors, age (HR, 1.20 per 10-year increase; 1.14 to 1.26) and female donor to male recipient sex mismatch (HR, 1.38; 1.06 to 1.80) were significantly associated with 1-year mortality. Quality of evidence was high.

None of the operative factors emerged as significant predictors of 1-year mortality.

Findings of the present study should inform future guideline and predictive model development, as well as the decision-making process undertaken between the clinician and patient, researchers said.

While the International Society of Heart and Lung Transplantation 2016 guidelines recommend that transplantation be considered for carefully selected candidates >70 years of age (class I, level of evidence: C), “our review suggests that increasing donor age and recipient age carries a 1-year mortality hazard of 20 and 16 percent for each 10-year increase, respectively. Hence, matching older recipients with older donors puts patients at a higher risk of 1-year mortality,” they said.

Nevertheless, more studies with better methodology are needed to reassess predictors of 1-year mortality, they added.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Dec 2017
Discontinuation of aspirin may have detrimental consequences for long-term users, with a recent study reporting that cessation of use in the absence of major surgery or bleeding increases the risk of cardiovascular events.
19 Dec 2016
The prevalence of ECG for left ventricular hypertrophy (LVH) may vary depending on the criteria used across body mass index (BMI) categories in a low cardiovascular risk cohort, suggests a new study.
01 Mar 2015
Red yeast rice extracts have been used in traditional medicine for centuries.1 In recent times, an extract from red yeast rice, Xuezhikang® (XZK), has been studied for its role in dyslipidaemia and cardiovascular disease. This review will look at some of the clinical trials that have done so.
Pearl Toh, 8 hours ago
A higher dose of pitavastatin can benefit Japanese patients with stable coronary artery disease (CAD) compared with a low-dose pitavastatin, even though cardiovascular (CV) event incidence is known to be lower in Asian than Western patients, according to the REAL-CAD study presented at the AHA Scientific Sessions 2017.